UK markets close in 5 hours 42 minutes

Alimera Sciences, Inc. (ASZ1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
3.3200-0.1350 (-3.91%)
As of 08:15AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 184.52M
Enterprise value 234.03M
Trailing P/E N/A
Forward P/E 123.46
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.18
Price/book (mrq)4.22
Enterprise value/revenue 2.90
Enterprise value/EBITDA -209.89

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3107.81%
S&P500 52-week change 324.49%
52-week high 33.8300
52-week low 31.4400
50-day moving average 33.3820
200-day moving average 33.2018

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 552.37M
Implied shares outstanding 653.41M
Float 88.06M
% held by insiders 15.97%
% held by institutions 192.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 315 Nov 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -24.93%
Operating margin (ttm)2.75%

Management effectiveness

Return on assets (ttm)-1.23%
Return on equity (ttm)-158.76%

Income statement

Revenue (ttm)80.75M
Revenue per share (ttm)3.16
Quarterly revenue growth (yoy)87.50%
Gross profit (ttm)N/A
EBITDA 6.82M
Net income avi to common (ttm)-21.39M
Diluted EPS (ttm)-0.7800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.06M
Total cash per share (mrq)0.23
Total debt (mrq)67.4M
Total debt/equity (mrq)145.98%
Current ratio (mrq)2.39
Book value per share (mrq)0.88

Cash flow statement

Operating cash flow (ttm)-14.26M
Levered free cash flow (ttm)-80.36M